Rituximab – VJRegenMed https://mirror.vjregenmed.com The Video Journal of Regenerative Medicine Tue, 16 Aug 2022 09:40:06 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.2 https://d2xz56kaqxj8if.cloudfront.net/wp-content/uploads/2023/09/12102509/VJR-Favicon.png Rituximab – VJRegenMed https://mirror.vjregenmed.com 32 32 The advantages of the CABA™ platform for treating B-cell-mediated autoimmune diseases https://mirror.vjregenmed.com/video/khaax1vdkgi-the-advantages-of-the-caba-platform-for-treating-b-cell-mediated-autoimmune-diseases/ Thu, 27 Jan 2022 18:00:58 +0000 http://13.40.107.223/video/khaax1vdkgi-the-advantages-of-the-caba-platform-for-treating-b-cell-mediated-autoimmune-diseases/ Samik Basu, MD, Cabaletta Bio, Philadelphia, PA, comments on the benefits of the Cabaletta Approach to selective B cell Ablation (CABA™) platform over standard of care treatments for B-cell-mediated autoimmune diseases such as rituximab or steroids, which result in broad immunosuppression which may be dangerous for patients. The CABA™ platform selectively eliminates specific autoantibody-producing B cells, minimizing adverse events and avoiding immunosuppression. This interview took place at Advanced Therapies Week 2022.

]]>